Today, Alzheimer’s disease (AD) is the sixth leading cause of death in the United States, with a striking effect on one in ten people aged 65 and over. Music therapy (MT) is a non-pharmacological treatment for AD that is particularly significant because, as AD progresses, patients maintain their music memory despite the loss of other cognitive functions. This knowledge begged the question: how frequently is clinical music therapy used to treat Alzheimer’s disease? Is everyone who can benefit from music therapy being exposed to it? These questions will be addressed using case study research that will determine the frequency of music therapy usage in care facilities and explore the underlying reasons, if any, behind resistance against MT. Qualitative data will be gathered through interviews with music therapists and activity directors at care facilities to determine various perspectives on the effectiveness of MT.